Dr Brian E. Jahns is an accomplished pharmaceutical business leader with robust and progressive commercialization experience in the biopharmaceutical industry.
Brian works for Entheon Biomedical Corp., as Chief Business Officer. Entheon Biomedical is a clinical stage psychiatry company developing innovative small molecules, drug formulations and biomarkers to improve the care of patients living with addiction and substance use disorder.
Previously, Brian was Vice-President, Global Marketing at ZYUS Life Sciences Inc., a clinical stage phyto-therapeutics company working to address chronic and refractory pain.
Prior to joining ZYUS, Brian worked as Senior Vice-President, Commercial and Business Development for Trillium Therapeutics Inc. In this role, Brian was responsible for providing commercial direction into the clinical and regulatory strategy, as well as executing business development activities for this clinical stage immune-oncology company.
Earlier in his career, Brian worked at Hoffmann-La Roche, Ltd., in a variety of medical, marketing, and sales leadership roles where he was intimately involved in the successful launch and growth of several antivirals, transplant immunosuppressants and anticancer biologics. He developed a keen interest in factors influencing optimized patient care, including the promise of personalized medicine, the intricacies of how medicines are used and the connection between funding and the ability to improve outcomes. Brian rose to become Vice President of Oncology, and then Vice President of Product Strategy at Roche Canada.
Enter your email to get the latest developments on N-Zyme, including our research, clinical trials and corporate reports.